Literature DB >> 15720211

Integral therapeutic potential of bone marrow mesenchymal stem cells.

I Kan1, E Melamed, D Offen.   

Abstract

Bone marrow derived mesenchymal stem cells (MSC) are adult stem cells that reside within the bone marrow compartment. In the traditional developmental model, adult stem cells are able to differentiate only to the tissue in which they reside. Recent data have challenged the committed fate of the adult stem cells, presenting evidence for their multi-lineage differentiation potential. In addition, potential therapeutic benefits of MSC administration have been the main concern of much research, including clinical trials. These studies promote adult stem cell therapy by shedding some light on the therapeutic potential of MSC and their mechanism of action. Many doubts have found their way into MSC research. They question MSC potency and beneficial contribution. However, these obstacles should not arrest but set a challenge to MSC researchers to examine their achievements under a magnifying glass. Therapeutic benefits of MSC exogenous delivery do not run counter to its possible participation in endogenous repair. Several reports imply MSC involvement in physiological repair but no explicit data support this hypothesis. This review tries to put MSC research into perspective. Possible therapeutic applications of MSC therapy for damaged tissue replacement, tissue engineering and the underlying repair mechanisms will be discussed. In addition, reported data about MSC possible involvement in physiological multiple tissue repair, their homing to injury and site-specific differentiation will be presented.

Entities:  

Mesh:

Year:  2005        PMID: 15720211     DOI: 10.2174/1389450053344902

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  20 in total

Review 1.  Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles.

Authors:  Brett Hall; Jennifer Dembinski; A Kate Sasser; Matus Studeny; Michael Andreeff; Frank Marini
Journal:  Int J Hematol       Date:  2007-07       Impact factor: 2.490

2.  Effectiveness of protocol for the isolation of Wharton's Jelly stem cells in large-scale applications.

Authors:  Anastasia Petsa; Sofia Gargani; Antigonos Felesakis; Nikolaos Grigoriadis; Ioannis Grigoriadis
Journal:  In Vitro Cell Dev Biol Anim       Date:  2009-12       Impact factor: 2.416

3.  Novel Role of ER Stress and Mitochondria Stress in Serum-deprivation Induced Apoptosis of Rat Mesenchymal Stem Cells.

Authors:  Tong Qiu; Yan-Yan He; Xiao Zhang; Xiao-Lin Ma
Journal:  Curr Med Sci       Date:  2018-04-30

4.  Compressive elasticity of three-dimensional nanofiber matrix directs mesenchymal stem cell differentiation to vascular cells with endothelial or smooth muscle cell markers.

Authors:  K Wingate; W Bonani; Y Tan; S J Bryant; W Tan
Journal:  Acta Biomater       Date:  2012-01-08       Impact factor: 8.947

5.  In Vivo Growing of New Cell Colonies in a Portion of Bone Marrow: Potential Use for Indirect Cell Therapy.

Authors:  Ana Manzanedo; Fidel Rodriguez; Jose A Obeso; Manuel Rodriguez
Journal:  Cell Med       Date:  2010-11-05

6.  Therapeutic efficacy and safety of TRAIL-producing human adipose tissue-derived mesenchymal stem cells against experimental brainstem glioma.

Authors:  Seung Ah Choi; Sung-Kyun Hwang; Kyu-Chang Wang; Byung-Kyu Cho; Ji Hoon Phi; Ji Yeoun Lee; Hee Won Jung; Do-Hun Lee; Seung-Ki Kim
Journal:  Neuro Oncol       Date:  2010-11-09       Impact factor: 12.300

7.  Effect of culture complex of BMSCs and sodium hydroxide- and GRGDSPC-treated PET on the reconstruction of injured anterior cruciate ligament in a rabbit model.

Authors:  Jianming Huang; Fengrong Chen; Guojian Jian; Zhiyang Ye; Zimin Wang; Haoyuan Liu; Yifan Kang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

8.  IKK-2 is required for TNF-alpha-induced invasion and proliferation of human mesenchymal stem cells.

Authors:  Wolfgang Böcker; Denitsa Docheva; Wolf Christian Prall; Virginia Egea; Emmanouil Pappou; Oliver Rossmann; Cvetan Popov; Wolf Mutschler; Christian Ries; Matthias Schieker
Journal:  J Mol Med (Berl)       Date:  2008-07-04       Impact factor: 4.599

Review 9.  Stem cell-based therapies for tumors in the brain: are we there yet?

Authors:  Khalid Shah
Journal:  Neuro Oncol       Date:  2016-06-09       Impact factor: 12.300

10.  Therapeutic potential of genetically modified adult stem cells for osteopenia.

Authors:  S Kumar; T R Nagy; S Ponnazhagan
Journal:  Gene Ther       Date:  2009-09-10       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.